A diagnosis of ATTR-CM in a more recent era was associated with older age, White race, wild‐type disease, and tafamidis treatment. The survival of patients diagnosed with transthyretin-mediated ...

Coramitug is well tolerated and leads to a statistically significant reduction in N-terminal pro-brain type natriuretic peptide (NT-proBNP)—a marker of disease progression in transthyretin-mediated ...

A pattern recognition approach takes into account factors like disease progression rate, whether the disease symptoms are symmetrical or asymmetrical, whether they are predominantly distal or proximal ...

Analyzing the phenotypes of patients with IgG4-related autoimmune pancreatitis can lead to more personalized treatment and, hopefully, better outcomes. Autoimmune pancreatitis (AIP) associated with ...

Neonatal intensive care units (NICUs) were something I knew very little about in my first 2 pregnancies. My first child was born 9 days late. My second child was born just a few days before my due ...

Intravenous immunoglobulin-induced thrombocytopenia was reported in 146 cases, with the highest incidence seen in patients with immune-mediated skin diseases. Intravenous immunoglobulin (IVIg) therapy ...

The updated 2025 BSR management recommendations for patients with AAV provide systematic and evidence-based recommendations to support UK clinicians in managing AAV across the entire life course.

Ruxolitinib exerts its activity independently of oncogenic Janus kinase 2 (JAK2)-V617F signaling in myeloproliferative neoplasms (MPNs) like myelofibrosis (MF), according to a new study published in ...

Treatment discontinuation rates were similar to those in the placebo group, and no notable safety imbalances were observed for serious adverse events. Nerandomilast, an investigational oral ...

Although treatment was started with rituximab upon the CAD diagnosis, she died within 5 days. A case has been reported of a patient with a history of Raynaud’s phenomenon who was hospitalized due to ...

Relative survival increased from 64% to 66%, overall survival from 54% to 55%, and lymphoma-specific survival from 64% to 66%. The advent of chimeric antigen receptor T-cell (CAR-T) therapy for ...

Extremely low baseline neutrophil count was a strong predictor of early death, underscoring the need for early risk stratification. Treatment with porcine antihuman T-lymphocyte globulin (ATG) and ...